{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:45:55Z","timestamp":1793241955331,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.neurobiolaging.2007.04.006","type":"journal-article","created":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T07:58:12Z","timestamp":1180511892000},"page":"1690-1701","source":"Crossref","is-referenced-by-count":424,"title":["Synuclein activates microglia in a model of Parkinson's disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Xiaomin","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Maguire-Zeiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landa","family":"Prifti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Federoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/hmg\/8.4.567","article-title":"A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's disease","volume":"8","author":"Abbas","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib2","first-page":"29","article-title":"Age-related susceptibility to MPTP-induced neurotoxicity in mice","volume":"14","author":"Ali","year":"1993","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(00)01049-1","article-title":"Alph-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells","volume":"285","author":"Ancolio","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib4","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib5","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1523\/JNEUROSCI.23-07-02665.2003","article-title":"A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation","volume":"23","author":"Bamberger","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3171\/jns.1990.72.2.0231","article-title":"The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies","volume":"72","author":"Bankiewicz","year":"1990","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","article-title":"Experimental models of Parkinson's disease","volume":"2","author":"Beal","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(00)01153-8","article-title":"Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects","volume":"287","author":"Borghi","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1196\/annals.1332.008","article-title":"Inflammation, neurodegenerative diseases, and environmental exposures","volume":"1035","author":"Campbell","year":"2004","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-9440(10)64354-4","article-title":"CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils","volume":"160","author":"Coraci","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/neu.10094","article-title":"Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP","volume":"53","author":"Dong","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1749-6632.1992.tb24537.x","article-title":"Overview of Parkinson's disease","volume":"648","author":"Duvoisin","year":"1992","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib15","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1084\/jem.20021546","article-title":"CD36 mediates the innate host response to beta-amyloid","volume":"197","author":"El Khoury","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","article-title":"Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma","volume":"77","author":"El-Agnaf","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib17","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1523\/JNEUROSCI.2922-05.2005","article-title":"Neural activity controls the synaptic accumulation of alpha-synuclein","volume":"25","author":"Fortin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib18","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","article-title":"Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro","volume":"274","author":"Giasson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(02)02422-8","article-title":"MPP+ increases alpha-synuclein expression and ERK\/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells","volume":"935","author":"Gomez-Santos","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.2003.tb07475.x","article-title":"Transgenic models of alpha-synuclein pathology: past, present, and future","volume":"991","author":"Hashimoto","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(00)01589-5","article-title":"Cellular dopamine is increased following exposure to a factor derived from immortalized striatal neurons in humans","volume":"295","author":"Heller","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0006-8993(96)00345-9","article-title":"Glial-derived neurotrophic factor (GDNF) induced morphological differentiation of an immortalized monoclonal hybrid dopaminergic cell line of mesencephalic neuronal origin","volume":"725","author":"Heller","year":"1996","journal-title":"Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neurobiolaging.2007.04.006_bib23","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.parkreldis.2004.10.013","article-title":"Neuroinflammatory processes in Parkinson's disease","volume":"11","author":"Hirsch","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1568010053586237","article-title":"Mechanisms of cell signaling and inflammation in Alzheimer's disease","volume":"4","author":"Ho","year":"2005","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/glia.10148","article-title":"Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system","volume":"40","author":"Husemann","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0165-5728(01)00239-9","article-title":"Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar beta-amyloid","volume":"114","author":"Husemann","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","article-title":"Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity","volume":"57","author":"Irizarry","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib28","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","article-title":"Subcellular localization of wild-type and Parkinson's disease- associated mutant alpha-synuclein in human and transgenic mouse brain","volume":"20","author":"Kahle","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease","volume":"38","author":"Kim","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the Parkin gene cause autosomal recessive juvenile Parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s100489900083","article-title":"Progress in the clinical and molecular genetics of familial Parkinsonism","volume":"2","author":"Kitada","year":"2000","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib32","article-title":"alpha-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia","author":"Klegeris","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/mcne.2000.0914","article-title":"Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2","volume":"16","author":"Knott","year":"2000","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","article-title":"Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Kohutnicka","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","article-title":"MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons","volume":"77","author":"Kowall","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-1-23","article-title":"beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins","volume":"1","author":"Kunjathoor","year":"2004","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib39","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(84)90293-3","article-title":"1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra","volume":"48","author":"Langston","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib41","first-page":"49","article-title":"MPTP-induced parkinsonism in human and non-human primates-clinical and experimental aspects","volume":"100","author":"Langston","year":"1984","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib42","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib43","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53\u2192Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention","volume":"304","author":"Liu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1749-6632.2003.tb07473.x","article-title":"Convergent pathobiologic model of Parkinson's disease","volume":"991","author":"Maguire-Zeiss","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib46","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.bbrc.2006.08.127","article-title":"Identification of human alpha-synuclein specific single chain antibodies","volume":"349","author":"Maguire-Zeiss","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib47","first-page":"13","article-title":"The herbicide paraquat causes upregulation and aggregation of alpha-synuclein in mice","volume":"13","author":"Manning-Bog","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib48","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein","volume":"277","author":"Manning-Bog","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib49","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib50","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","article-title":"Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter","volume":"8","author":"Matsuoka","year":"2001","journal-title":"Neurobiol. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2007.04.006_bib52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2005.08.008","article-title":"Inflammation, the complement system and the diseases of aging","volume":"26","author":"McGeer","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib53","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib54","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1332.007","article-title":"Inflammation and the degenerative diseases of aging","volume":"1035","author":"McGeer","year":"2004","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib55","doi-asserted-by":"crossref","first-page":"10643","DOI":"10.1074\/jbc.M311735200","article-title":"Fibrillar amyloid protein present in atheroma activates CD36 signal transduction","volume":"279","author":"Medeiros","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.mp.4000446","article-title":"Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease","volume":"3","author":"Mezey","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib57","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1523\/JNEUROSCI.4204-03.2004","article-title":"Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra","volume":"24","author":"Miller","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib58","doi-asserted-by":"crossref","first-page":"47373","DOI":"10.1074\/jbc.M208788200","article-title":"A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid","volume":"277","author":"Moore","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib59","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00001756-199903170-00012","article-title":"Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines","volume":"10","author":"Peyrin","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1749-6632.2000.tb06901.x","article-title":"Genetics of Parkinson's disease","volume":"920","author":"Polymeropoulos","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib61","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson's disease to chromosome 4q21-q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib62","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1471-4159.2001.00174.x","article-title":"Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib64","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib65","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1046\/j.1471-4159.2001.00366.x","article-title":"Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice","volume":"77","author":"Rathke-Hartlieb","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.2002.7882","article-title":"Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice","volume":"175","author":"Richfield","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib67","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","article-title":"Neurochemical findings in the MPTP model of Parkinson's disease","volume":"108","author":"Schmidt","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(90)91055-L","article-title":"Dose-dependent destruction of the coeruleus-cortical and nigral\u2013striatal projections by MPTP","volume":"527","author":"Seniuk","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib69","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","article-title":"Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation","volume":"97","author":"Serpell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib70","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","article-title":"Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP","volume":"186","author":"Song","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib72","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-1119(99)00045-1","article-title":"Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector","volume":"229","author":"Strathdee","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib74","doi-asserted-by":"crossref","first-page":"25216","DOI":"10.1074\/jbc.M503341200","article-title":"Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases","volume":"280","author":"Sung","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib75","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJM200012143432404","article-title":"Familial aggregation of Parkinson's disease in Iceland","volume":"343","author":"Sveinbjornsdottir","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib76","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/hmg\/9.18.2683","article-title":"Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity","volume":"9","author":"Tabrizi","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib77","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib78","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.0953-816X.2004.03139.x","article-title":"Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice","volume":"19","author":"Thiruchelvam","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.104.070961","article-title":"Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation","volume":"311","author":"Thomas","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib80","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","article-title":"Neuropathology in mice expressing human alpha-synuclein","volume":"20","author":"van der Putten","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0306-4522(94)90006-X","article-title":"Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease","volume":"63","author":"Varastet","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1389203043486937","article-title":"Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease","volume":"5","author":"Verdier","year":"2004","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib83","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2007.04.006_bib84","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458007001674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458007001674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T08:55:34Z","timestamp":1556441734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458007001674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0197458007001674"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.04.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}